4//SEC Filing
Davis Andrew 4
Accession 0001209191-23-017873
CIK 0001446847other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 5:07 PM ET
Size
7.3 KB
Accession
0001209191-23-017873
Insider Transaction Report
Form 4
Davis Andrew
SVP, Chief Business Officer
Transactions
- Award
Class A Common Stock
2023-03-08+74,236→ 225,632 total - Award
Performance-based Restricted Stock Units
2023-03-08+37,118→ 37,118 totalExp: 2026-02-28→ Class A Common Stock (37,118 underlying)
Footnotes (2)
- [F1]The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
- [F2]Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001932525
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 5:07 PM ET
- Size
- 7.3 KB